[{"Year":"2007","Value":94.1,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2008","Value":95.3,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2009","Value":95.4,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2010","Value":96.5,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2011","Value":95.1,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2012","Value":96.2,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2013","Value":96.9,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2014","Value":95.8,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2015","Value":96.6,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2016","Value":96.1,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2017","Value":93.4,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2018","Value":94.5,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2019","Value":94.351083,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2020","Value":88.157251,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":"2007","Value":98.8,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2008","Value":99.1,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2009","Value":98.9,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2010","Value":98.3,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2011","Value":97.2,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2012","Value":97.7,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2013","Value":98.666102,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2014","Value":95.6,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2015","Value":99.1,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2016","Value":97.0,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2017","Value":94.7,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2018","Value":96.244215,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2019","Value":97.245414,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2020","Value":93.789319,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":"2015","Value":96.8,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2016","Value":97.2,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2017","Value":94.2,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2018","Value":92.0,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2019","Value":95.083643,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":"2020","Value":88.782542,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"}]